Boceprevir With Peginterferon Alfa-2a–Ribavirin Is Effective for Previously Treated Chronic Hepatitis C Genotype 1 Infection

Clinical Gastroenterology and Hepatology ◽

10.1016/j.cgh.2012.10.006 ◽

2013 ◽

Vol 11 (1) ◽

pp. 81-87.e4 ◽

Author(s):

Steven L. Flamm ◽

Eric Lawitz ◽

Ira Jacobson ◽

Marc Bourlière ◽

Christophe Hezode ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Previously Treated ◽

Peginterferon Alfa

Download Full-text

Exam 2: Boceprevir With Peginterferon Alfa-2a–Ribavirin Is Effective for Previously Treated Chronic Hepatitis C Genotype 1 Infection

Clinical Gastroenterology and Hepatology ◽

10.1016/j.cgh.2012.10.034 ◽

2013 ◽

Vol 11 (1) ◽

pp. e5

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Previously Treated ◽

Peginterferon Alfa

Download Full-text

Faculty Opinions recommendation of Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirin.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718013666.793491356 ◽

2014 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Sustained Virological Response ◽

Chronic Hepatitis C ◽

Virological Response ◽

Dosing Regimen ◽

Peginterferon Alfa

Download Full-text

Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia

Journal of Hepatology ◽

10.1016/j.jhep.2005.10.003 ◽

2006 ◽

Vol 44 (1) ◽

pp. 97-103 ◽

Author(s):

Stefan Zeuzem ◽

Maria Buti ◽

Peter Ferenci ◽

Jan Sperl ◽

Yves Horsmans ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Peginterferon Alfa

Download Full-text

Overall safety profile of boceprevir plus peginterferon alfa-2b and ribavirin in patients with chronic hepatitis C genotype 1: a combined analysis of 3 phase 2/3 clinical trials

Liver International ◽

10.1111/liv.12300 ◽

2013 ◽

Vol 34 (5) ◽

pp. 707-719 ◽

Author(s):

Michael P. Manns ◽

Jonathan McCone ◽

Mitchell N. Davis ◽

Lorenzo Rossaro ◽

Eugene Schiff ◽

...

Keyword(s):

Clinical Trials ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Safety Profile ◽

Phase 2 ◽

Combined Analysis ◽

Peginterferon Alfa

Download Full-text

1163 A PHASE 2A STUDY OF BMS-791325, AN NS5B POLYMERASE INHIBITOR, WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION

Journal of Hepatology ◽

10.1016/s0168-8278(12)61175-1 ◽

2012 ◽

Vol 56 ◽

pp. S460 ◽

Author(s):

H. Tatum ◽

P. Thuluvath ◽

E. Lawitz ◽

C.T. Martorell ◽

M. Demicco ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Hepatitis C Infection ◽

Ns5b Polymerase Inhibitor ◽

Treatment Naïve ◽

Polymerase Inhibitor ◽

Peginterferon Alfa ◽

Ns5b Polymerase

Download Full-text

Sa1052 Triple Therapy Under Real Life Conditions: Telaprevir (TVR) in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) in NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1. The PAN Study

Gastroenterology ◽

10.1016/s0016-5085(13)63650-1 ◽

2013 ◽

Vol 144 (5) ◽

pp. S-983

Author(s):

Gero Moog ◽

Stefan Mauss ◽

Dietrich Hueppe ◽

Ulrich Spengler ◽

Eckart Schott ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Triple Therapy ◽

Chronic Hepatitis C ◽

Real Life ◽

Life Conditions ◽

Peginterferon Alfa

Download Full-text

746 NARLAPREVIR AND PEGINTERFERON ALFA-2B FOR 2 WEEKS IN CHRONIC HEPATITIS C GENOTYPE 1 PATIENTS, FOLLOWED BY PEGINTERFERON ALFA-2B AND RIBAVIRIN FOR 24/48 WEEKS: FINAL RESULTS

Journal of Hepatology ◽

10.1016/s0168-8278(10)60748-9 ◽

2010 ◽

Vol 52 ◽

pp. S290-S291 ◽

Author(s):

J. de Bruijne ◽

J.F. Bergmann ◽

C.J. Weegink ◽

R. Molenkamp ◽

J. Schinkel ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Peginterferon Alfa

Download Full-text

Effect of daily interferon alfacon-1 on response rates of previously treated non-responder chronic hepatitis C patients, with emphasis on rates in african american and genotype 1 populations-a preliminary report

Gastroenterology ◽

10.1016/s0016-5085(00)81772-2 ◽

2000 ◽

Vol 118 (4) ◽

pp. A1468

Author(s):

Jonathan McCone ◽

Julie Baldwin ◽

Bonnie McCone

Keyword(s):

African American ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Preliminary Report ◽

Response Rates ◽

Previously Treated ◽

Chronic Hepatitis C Patients

Download Full-text

Sa1041 Triple Therapy Under Real Life Conditions: Telaprevir (TVR) and Boceprevir (BOC) in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1. the PAN Study

Gastroenterology ◽

10.1016/s0016-5085(13)63639-2 ◽

2013 ◽

Vol 144 (5) ◽

pp. S-980 ◽

Author(s):

Gero Moog ◽

Stefan Mauss ◽

Dietrich Hueppe ◽

Ulrich Spengler ◽

Eckart Schott ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Triple Therapy ◽

Chronic Hepatitis C ◽

Real Life ◽

Life Conditions ◽

Peginterferon Alfa

Download Full-text

Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirin

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.12342 ◽

2013 ◽

Vol 38 (1) ◽

pp. 16-27 ◽

Author(s):

S. C. Gordon ◽

E. M. Yoshida ◽

E. J. Lawitz ◽

B. R. Bacon ◽

M. S. Sulkowski ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Sustained Virological Response ◽

Chronic Hepatitis C ◽

Virological Response ◽

Dosing Regimen ◽

Peginterferon Alfa

Download Full-text